IP Law Daily
A complete daily report of the intellectual property news that affects your practice, your clients and your world.
Breaking news and expert analysis on Intellectual Property Law.
What good is the right knowledge if it’s at the wrong time?
A complete daily report of the news that affects your world
- View full summaries of federal and state court decisions
- Access full text of legislative and regulatory developments
- Customize your daily email by topic and/or jurisdiction
- Search archives for stories of interest
Not just news – the right news
- Get expert analysis written by subject matter specialists—created by attorneys for attorneys
- Track law firms and organizations in the headlines with our new “Who’s in the News” feature
- Promote your firm with our permissions policy.
24/7 access for a 24/7 world
- Forward information with special copyright permissions, encouraging collaboration between counsel and colleagues
- Save time with mobile apps for your iPhone, iPad, or Android
- Access all links from any mobile device without being prompted for user name and password
German company’s patent suit against Sirius XM Radio reinstated
The district court erred by dismissing the infringement suit against the satellite radio company based on a license agreement.
Application’s claims for mode-switching handheld device improperly rejected
Prior art that disclosed a device able to transition from one operational mode to another did not disclose all limitations of the applied-for claims and therefore did not anticipate them.
Obviousness finding for fiberglass insulation patents not supported by substantial evidence
The PTAB’s finding of a motivation to combine based on similarity of the references was unsupported by substantial evidence.
Rival wood-pellet grill maker barred from using inventor's name and image
A wood pellet grill maker prevailed on a preliminary injunction claim against a rival grill maker which sought to use the grill's inventor in its advertising.
Nearly all asserted claims of patents for formulations of Horizon’s PENNSAID® 2% topical solution invalid as indefinite
Horizon also failed to show that competitor Actavis’s ANDA label induced infringement of asserted method claims.